Open access
88
Views
19
CrossRef citations to date
0
Altmetric
Original Research
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
Sanjay Sethi1 Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, Buffalo, NY, USA, [email protected]Correspondence[email protected]
, Edward Kerwin2 Clinical Research Institute, Medford, OR, USA
, Henrik Watz3 Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany
, Gary T Ferguson4 Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA
, Robert M Mroz5 Centrum Medycyny Oddechowej, Białystok, Poland;6 Medical University of Białystok, Białystok, Poland
, Rosa Segarra7 AstraZeneca, Barcelona, Spain
, Eduard Molins7 AstraZeneca, Barcelona, Spain
, Diana Jarreta7 AstraZeneca, Barcelona, Spain
& Esther Garcia Gil7 AstraZeneca, Barcelona, Spain
show all
Pages 667-682
|
Published online: 22 Mar 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.